Aryl Alkenamides Derivatives As Mcp-1 Antagonists

Abstract

Aryl alkenamides derivatives of Formula I or a pharmaceutically acceptable salt thereof are novel MCP-1 antagonists and are thus useful in the treatment of inflammation, atherosclerosis, restenosis, and immune disorders such as arthritis and transplant rejectionwhereV=O,S, NH or a bond;Ar can be unsubstituted or substituted benzimidazole, phenyl, biphenyl, pyridyl, naphthyl, quinoline or isoquinoline. The other meanings for the terms are recited in the specification below.


Claims
Owners (US)

Information currently unavailable.

CPC Classifications
IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Oct 1, 2002
  • Application: Aug 12, 1997
    US US 90979097 A
  • Priority: Aug 12, 1997
    US US 90979097 A
  • Priority: Aug 15, 1996
    US US 2396696 P

Download Citation


Sign in to the Lens

Feedback